AI-driven healthcare solutions provider Tempus AI (TEM) has disclosed acquisition of Deep 6 AI, a precision research platform for healthcare and life sciences companies. This deal will integrate Deep 6 AI’s advanced technology, which makes finding clinical trial matches faster and easier using real-time medical records, into Tempus’ platform.
At the same time, renowned investor Cathie Wood has shown confidence in Tempus AI by capitalizing on the recent dip in its share price. Over the past five days, Tempus AI stock has declined by 7.5%.
Key Benefits from Deep 6 AI Acquisition
Among the key benefits, the deal will help Tempus reach more people and improve the care it provides. This is possible as Deep 6 AI works with over 750 healthcare sites and connects to more than 30 million patients.
Further, Deep 6 AI’s platform matches patients to clinical trials using real-time medical data. This capability complements Tempus’ existing tools, such as the TIME platform, which helps patients find potentially life-saving clinical trials.
In addition, Deep 6 AI will improve how Tempus connects with healthcare providers, making it easier to close care gaps and give personalized treatments.
Cathie Wood Loads Up Tempus AI Stock
Cathie Wood’s ARK Investment Management has actively purchased TEM stock in 2025 so far, reflecting optimism about the company’s growth potential.
In January, ARK purchased 618,000 shares. This was followed by the acquisition of 527,000 shares in February, further boosting its position. On March 6, 2025, ARK acquired 270,802 shares across its ARKK and ARKG ETFs, totaling nearly $14.37 million in value.
Shortly after, on March 11, ARK added another 94,251 shares, worth around $4.26 million. These transactions highlight ARK’s bullish outlook on Tempus AI, particularly its role in advancing AI-driven healthcare solutions.
Is TEM a Good Stock to Buy?
Turning to Wall Street, TEM stock has a Moderate Buy consensus rating based on five Buys and five Holds assigned in the last three months. At $63.67, the average Tempus AI stock price target implies 39.69% upside potential.
Questions or Comments about the article? Write to editor@tipranks.com